Pharmaceutical Packaging Market Size & Share, by Type (Primary, Secondary), Material (Plastic, Glass, Metal, Paper), Product Type (Vials, Bottles, Blister Packs, Sachets, Syringes, Ampoules, Cartons & Boxes) - Global Supply & Demand Analysis, Growth Forecasts, Statistics Report 2024-2036

  • Report ID: 4616
  • Published Date: Jul 30, 2024
  • Report Format: PDF, PPT

Global Market Size, Forecast, and Trend Highlights Over 2024-2036

Pharmaceutical Packaging Market size was over USD 116.75 Billion in 2023 and is poised to cross USD 321.35 Billion by the end of 2036, growing at more than 8.1% CAGR during the forecast period i.e., between 2024-2036. In the year 2024, the industry size of pharmaceutical packaging is estimated at USD 125.26 Billion. This can be attributed to the growing health concerns and the increased use of medicines worldwide. Further there has been rise in adoption of generic drugs which is also estimated to boost the growth of the market over the forecast period. Currently, 90% (9 out of 10) of all prescriptions written in the United States are for generic medications. Since it is necessary to pack and safeguard medications during storage and transportation, this packaging plays a significant part in the manufacturing of generic medications. Consequently, the use of pharmaceutical packaging would increase as the demand for generic medications rises.

Additionally, the manufacturing of novel drugs is also estimated to drive the market growth. The novel medicine packaging method has prefilled inhalers and syringes, which are single-dose vaccination units. The prefilled inhalers and syringes are made to prevent the packed medications from coming into direct touch with the patient or the environment, preventing contamination. By allowing for a self-administered metered dosage, it also decreases waste and increases patient compliance. Also, large number of pharmaceutical companies are shifting towards sustainable packaging owing to the growing concern for environment. They are extensively using recyclable materials and biodegradable packaging for packaging. One of the most extensively used material is polyethylene terephthalate by pharmaceutical companies. Hence owing to the rising adoption of sustainable packaging the market is estimated to boost further.


Pharmaceutical Packaging Market
Get more information on this report: Request Free Sample PDF

Pharmaceutical Packaging Sector: Growth Drivers and Challenges

Growth Drivers

  • Increasing World Medical Expenditure – People are spending more money than ever on healthcare to prevent sickness as modern healthcare facilities and better diagnostics evolve. In the United States, health spending and funding (per capita, current prices) grew from USD 11859.2 in 2020 to USD 12318.1 in 2021, according to the OECD.
  • Increased Government Spending on Healthcare – The figures for the U.S. showed that government spending on healthcare increased by nearly 35% in 2020, a major increase from the 6% growth in 2019. This expansion was more rapid in part because of the COVID-19 epidemic.
  • A Marked Rise in the Frequency of Chronic Diseases – Diseases which often require a long, undergoing treatment and are generally incurable are called chronic diseases. They often require regular medication to manage symptoms. According to the CDC, 6 out of 10 people in the U.S.  have at least one chronic disease, such as heart disease, diabetes, stroke or cancer.
  • Better and Safer Supply Chains – Better supply chains will reduce costs, and enhance the reach and use of pharmaceutical products, directly benefitting the pharmaceutical packaging market. Furthermore, pharma products need a proper cold chain logistics to cover a long distance, and it is expected to drive the growth of the market. Post-pandemic, the world has realized the importance of better supply chains, and over 60% of businesses feel they have a competitive advantage thanks to supply chain management.
  • Increased Use of Pharma Products Post-Pandemic – According to Our World in Data, 67.9% of the total people in the world have received at least the first dose of the COVID vaccine.  Over 12.71 billion doses have been used all over the world, and 3.5 million doses are being used per day. Each vaccine is contained inside a glass vial, and the pharmaceutical packaging market is benefitting from it.

Challenges

  • Growth in Counterfeit Pharmaceutical Drugs - A counterfeit pharmaceutical medication is purposefully and illegally mislabeled in terms of its identity. Pharmaceutical products that are phoney may have the proper components, the incorrect ingredients, no active ingredients, the incorrect ingredients with an incorrect amount of an active ingredient, or fraudulent packaging. With the prevalence of fake goods increasing, the market for pharmaceutical packaging is facing a significant obstacle.
  • Breakages, Spillage and Improper Handling
  • Maintaining Sustainability and Preventing Environmental Harm

Pharmaceutical Packaging Market: Key Insights

Base Year

2023

Forecast Year

2024-2036

CAGR

8.1%

Base Year Market Size (2023)

USD 116.75 Billion

Forecast Year Market Size (2036)

USD 321.35 Billion

Regional Scope

  • North America (U.S., and Canada)
  • Latin America (Mexico, Argentina, Rest of Latin America)
  • Asia-Pacific (Japan, China, India, Indonesia, Malaysia, Australia, Rest of Asia-Pacific)
  • Europe (U.K., Germany, France, Italy, Spain, Russia, NORDIC, Rest of Europe)
  • Middle East and Africa (Israel, GCC North Africa, South Africa, Rest of the Middle East and Africa)
Get more information on this report: Request Free Sample PDF

Pharmaceutical Packaging Segmentation

Material (Plastic, Glass, Metal, Paper)

The global pharmaceutical packaging market is segmented and analyzed for demand and supply by material into plastic, glass, metal, paper, and others. Out of which the plastic segment is anticipated to hold the largest market share over the forecast period. The growth of this segment can be attributed to its growing preference for packaging of tablets and capsules. Further, they also extensively used for packing liquid dose like syrups, and nasal. Approximately 19% of the weight of all pharmaceutical packaging is currently made up of plastic. Plastics are a diverse set of rigid composite materials that are primarily organic and that could be cast, molded, or directly polymerized into form, typically by applying pressure and heat separately or in combination. They benefit from being light in weight, simple to process, break resistant, tamper proof, pilfer proof, and corrosion resistant. Hence their demand in pharmaceutical companies for packaging is estimated to boost.

Type (Primary, Secondary)

The global pharmaceutical packaging market is also segmented and analyzed for demand and supply by type into primary and secondary. Amongst these segments, the primary segment is anticipated to generate the largest revenue in the market. Primary packaging, often known as retail packaging or POS (Point-of-Sale) packaging, is the package that comes into direct touch with the product. Primary packaging's major goals are product preservation and consumer education. In order to shield the product from the environment, it is typically composed of materials that are impermeable to air, light, and moisture. It is foremost procedure in packaging of medicine and hence can’t be avoided. Therefore, owing to the growth of the segment is anticipated to increase.

Our in-depth analysis of the global market includes the following segments:

                      By Type

  • Primary
  • Secondary

                      By Material

  • Plastic
  • Glass
  • Metal
  • Paper
  • Others

                    By Product Type

  • Vials
  • Bottles
  • Blister Packs
  • Sachets
  • Syringes
  • Ampoules
  • Cartons & Boxes

Want to customize this research report as per your requirements? Our research team will cover the information you require to help you take effective business decisions.

Customize this Report

Pharmaceutical Packaging Industry - Regional Synopsis

North American Market Forecast

The North American pharmaceutical packaging market, amongst the market in all the other regions, is projected to hold the largest market share by the end of 2036, backed by reshoring of pharmaceutical manufacture in the region, the growth of production facilities, and partnerships between pharmaceutical companies and CMOs to boost the supply of medications. In addition, rising government spending on COVID-19-related medicines is driving up pharmaceutical packaging demand in North America. However, the market in Asia Pacific region is to grow faster over the forecast period. This is anticipated by growing spending on healthcare in this region. For instance, the APAC region's average healthcare benefit cost trend increased from about 5% in 2020 to approximately 10% in 2021 before falling to about 4% in 2022. Costs are anticipated to increase by an estimated 11% in 2023.Furthermore, the surging awareness related to the zero waste packaging in the pharma industry is further predicted to boost the market’s growth in the region.

Research Nester
Pharmaceutical Packaging Market Size
Get more information on this report: Request Free Sample PDF

Companies Dominating the Pharmaceutical Packaging Landscape

    • Becton, Dickinson, and Company
      • Company Overview
      • Business Strategy
      • Key Product Offerings
      • Financial Performance
      • Key Performance Indicators
      • Risk Analysis
      • Recent Development
      • Regional Presence
      • SWOT Analysis
    • Amcor plc
    • AptarGroup, Inc.
    • Drug Plastics Group
    • Gerresheimer AG
    • Schott AG
    • Owens Illinois, Inc.
    • West Pharmaceutical Services, Inc.
    • Berry Global, Inc.
    • WestRock Company
    • SGD S.A.

In the News

  • Gerrsheimer AG has greatly increased the amount of glass and plastic it can produce in India. In the Kosamba location, a new cutting-edge facility was constructed to manufacture high quality plastic containers and closures, with cutting-edge, environmentally friendly furnace technology.

  • SGD S.A. launches of 100ml Ready-to-Use (RTU) Type I molded glass vials for aseptic fill/finish of parenteral medicinal formulations. It is the first product of its sort in an EZ-fill tray arrangement from a renowned glass packaging supplier.

Author Credits:  Abhishek Anil


  • Report ID: 4616
  • Published Date: Jul 30, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2024, the industry size of pharmaceutical packaging is estimated at USD 125.26 Billion.

The pharmaceutical packaging market size was over USD 116.75 Billion in 2023 and is poised to cross USD 321.35 Billion by the end of 2036, growing at more than 8.1% CAGR during the forecast period i.e., between 2024-2036. Increased healthcare expenditure, rising government spending, better supply chains and rise in chronic diseases are the major factors driving the market growth.

North America industry is predicted to account for largest revenue share by 2036, backed by reshoring of pharmaceutical manufacture in the region.

Becton, Dickinson, and Company, Amcor plc, AptarGroup, Inc., Drug Plastics Group, Gerresheimer AG, Schott AG, Owens Illinois, Inc., West Pharmaceutical Services, Inc., Berry Global, Inc., WestRock Company, SGD S.A.

In the year 2024, the industry size of pharmaceutical packaging is estimated at USD 125.26 Billion.
Pharmaceutical Packaging Market Report Scope
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample